Navigation Links
Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing
Date:3/3/2010

IRVINE, Calif., March 3 /PRNewswire/ -- Avrio Biopharmaceuticals, LLC, a premier contract development and manufacturing organization, announced the addition of Yvonne Verburgt as Vice President of Business Development and Marketing. Yvonne brings over 28 years of pharmaceutical industry experience to the company and to the clients it serves.  

"We are very excited to bring Yvonne on board," said Assad J. Kazeminy, President and Founder of Avrio Biopharmaceuticals. "Yvonne brings years of experience with a remarkable track record to our executive team. She is an innovative and seasoned scientific sales leader and I look forward to the great contributions she will bring to the company and our clients."

Yvonne's most recent venture as the head of Business Development at Pharmatek Laboratories, Inc. involved successfully leading the sales team to help expand business of pharmaceutical chemistry development services. Her previous work experience includes serving as the Director of North American Sales for Patheon, Inc., and holding similar sales and management roles for companies including Oread, Inc., Becton Dickinson, Behring Diagnostics, Abbott Laboratories, and Johnson & Johnson. 

"Yvonne's extensive history in science and sales makes her an ideal addition to our executive team," said Aryo A. Nikopour, Vice President of Scientific and Technical Services. "She brings an impressive depth of knowledge and leadership skills and will be instrumental in building our customer-centric business."

You can learn more about Avrio and the executive team at the upcoming 2010 PDA Annual Meeting, booth 714.

About Avrio Biopharmaceuticals, LLC

Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, specializing in preformulation/formulation, analytical development, process validation, scale-up studies, packaging and labeling, stability storage and complete analytical CMC testing. Learn more at www.avriobiopharma.com or call 866-98-AVRIO (866-982-8746).

SOURCE Avrio Biopharmaceuticals, LLC

Back to top

RELATED LINKS
http://www.avriobiopharma.com
http://www.irvinepharma.com

'/>"/>

SOURCE Avrio Biopharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lumetra PSO Joins Forces With iSOFT Solutions
2. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
3. Top Bristol-Myers Squibb Executive Joins Patton Boggs
4. Government Relations CEO Joins MedeFile Advisory Board
5. Eamonn Hobbs Joins the Board of Directors at Cappella
6. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
7. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
8. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
9. New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nations First In Vitro Fertilization Insurance Program
10. CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
11. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):